Valero C, Zanoni DK, Pillai A, Ganly I, Morris LGT, Shah JP, et al. Host Factors Independently Associated With Prognosis in Patients With Oral Cavity Cancer. JAMA Otolaryngol Head Neck Surg. 2020;146:699–707.
PubMed
Google Scholar
Tham T, Bardash Y, Herman SW, Costantino PD. Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta-analysis. Head Neck. 2018;40:2546–57.
PubMed
Google Scholar
Starzer AM, Steindl A, Mair MJ, Deischinger C, Simonovska A, Widhalm G, et al. Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases. Br J Cancer Nature Publishing Group. 2021;124:1294–300.
CAS
Google Scholar
Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A, Jaillon S. Tumor associated macrophages and neutrophils in cancer. Immunobiology. 2013;218:1402–10.
CAS
PubMed
Google Scholar
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.
CAS
PubMed
PubMed Central
Google Scholar
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primer. 2020;6:92.
Google Scholar
Li M-X, Liu X-M, Zhang X-F, Zhang J-F, Wang W-L, Zhu Y, et al. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis. Int J Cancer. 2014;134:2403–13.
CAS
PubMed
Google Scholar
Wei Y, Jiang YZ, Qian WH. Prognostic Role of NLR in Urinary Cancers: A Meta-Analysis. PLOS ONE. 2014;9:e92079.
PubMed
PubMed Central
Google Scholar
Zhang X, Zhang W, Feng L. Prognostic Significance of Neutrophil Lymphocyte Ratio in Patients with Gastric Cancer: A Meta-Analysis. PLOS ONE. 2014;9:e111906.
PubMed
PubMed Central
Google Scholar
Yang J-J, Hu Z-G, Shi W-X, Deng T, He S-Q, Yuan S-G. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: A meta-analysis. World J Gastroenterol. 2015;21:2807–15.
PubMed
PubMed Central
Google Scholar
Yodying H, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Yamada M, et al. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol. 2016;23:646–54.
PubMed
Google Scholar
Baranyai Z, Jósa V, Tóth A, Szilasi Z, Tihanyi B, Zaránd A, et al. Paraneoplastic thrombocytosis in gastrointestinal cancer. Platelets. 2016;27:269–75.
CAS
PubMed
Google Scholar
Li B, Zhou P, Liu Y, Wei H, Yang X, Chen T, et al. Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis. Clin Chim Acta Int J Clin Chem. 2018;483:48–56.
CAS
Google Scholar
Pan YC, Jia ZF, Cao DH, Wu YH, Jiang J, Wen SM, et al. Preoperative lymphocyte-to-monocyte ratio (LMR) could independently predict overall survival of resectable gastric cancer patients. Medicine. 2018;97:e13896.
PubMed
PubMed Central
Google Scholar
Zhou S, Yuan H, Wang J, Hu X, Liu F, Zhang Y, et al. Prognostic value of systemic inflammatory marker in patients with head and neck squamous cell carcinoma undergoing surgical resection. Future Oncol Lond Engl. 2020;16:559–71.
CAS
Google Scholar
Shi H, Jiang Y, Cao H, Zhu H, Chen B, Weiwei Ji. Nomogram Based on Systemic Immune-Inflammation Index to Predict Overall Survival in Gastric Cancer Patients. Dis Markers. 2018; 1787424.
Simo R, Homer J, Clarke P, Mackenzie K, Paleri V, Pracy P, et al. Follow-up after treatment for head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130:S208–11.
CAS
PubMed
PubMed Central
Google Scholar
Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2002.
Google Scholar
Fine JP, Gray RJ. A Proportional Hazards Model for the Subdistribution of a Competing Risk. J Am Stat Assoc. 1999;94:496–509.
Google Scholar
Gray RJ. A Class of K-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk. Ann Stat. 1988;16:1141–54.
Google Scholar
Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247:2543–6.
PubMed
Google Scholar
Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell. 2011;144:646–74.
CAS
PubMed
Google Scholar
Granja S, Tavares-Valente D, Queirós O, Baltazar F. Value of pH regulators in the diagnosis, prognosis and treatment of cancer. Semin Cancer Biol. 2017;43:17–34.
CAS
PubMed
Google Scholar
Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493-503.
PubMed
Google Scholar
Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012;12:253–68.
CAS
PubMed
PubMed Central
Google Scholar
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.
CAS
PubMed
PubMed Central
Google Scholar
Shimasaki N, Jain A, Campana D. NK cells for cancer immunotherapy. Nat Rev Drug Discov. 2020;19:200–18.
CAS
PubMed
Google Scholar
Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12:298–306.
CAS
PubMed
Google Scholar
van der Leun AM, Thommen DS, Schumacher TN. CD8+ T cell states in human cancer: insights from single-cell analysis. Nat Rev Cancer. 2020;20:218–32.
PubMed
PubMed Central
Google Scholar
Guillerey C, Huntington ND, Smyth MJ. Targeting natural killer cells in cancer immunotherapy. Nat Immunol. 2016;17:1025–36.
CAS
PubMed
Google Scholar
Karpathiou G, Casteillo F, Giroult JB, Forest F, Fournel P, Monaya A, et al. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics. Oncotarget. 2017;8:19310–22.
PubMed
Google Scholar
Borsetto D, Tomasoni M, Payne K, Polesel J, Deganello A, Bossi P, et al. Prognostic Significance of CD4+ and CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis. Cancers. 2021;13:781.
CAS
PubMed
PubMed Central
Google Scholar
Tanaka R, Kimura K, Eguchi S, Tauchi J, Shibutani M, Shinkawa H, et al. Preoperative Neutrophil-to-lymphocyte Ratio Predicts Tumor-infiltrating CD8+ T Cells in Biliary Tract Cancer. Anticancer Res. 2020;40:2881–7.
CAS
PubMed
Google Scholar
Franz L, Alessandrini L, Fasanaro E, Gaudioso P, Carli A, Nicolai P, et al. Prognostic impact of neutrophils-to-lymphocytes ratio (NLR), PD-L1 expression and tumor immune microenvironment in laryngeal cancer. Ann Diagn Pathol. 2021;50:151657.
PubMed
Google Scholar
Ferrandino RM, Roof S, Garneau J, Haidar Y, Bates SE, Park YHA, et al. Neutrophil-to-lymphocyte ratio as a prognostic indicator for overall and cancer-specific survival in squamous cell carcinoma of the head and neck. Head Neck. 2020;42:2830–40.
PubMed
Google Scholar
Ueda T, Chikuie N, Takumida M, Furuie H, Kono T, Taruya T, et al. Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with clinical outcome in recurrent or metastatic head and neck cancer patients treated with nivolumab. Acta Otolaryngol. 2020;140:181–7.
CAS
PubMed
Google Scholar
Xu C, Yuan J, Du W, Wu J, Fang Q, Zhang X, Li H. Significance of the Neutrophil-to-Lymphocyte Ratio in p16-Negative Squamous Cell Carcinoma of Unknown Primary in Head and Neck. Front Oncol. 2020;10:39.
PubMed
PubMed Central
Google Scholar
Bojaxhiu B, Templeton AJ, Elicin O, Shelan M, Zaugg K, Walser M, et al. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation. Radiat Oncol. 2018;13:216.
CAS
PubMed
PubMed Central
Google Scholar
Noy R, Pollard JW. Tumor-Associated Macrophages: From Mechanisms to Therapy. Immunity. 2014;41:49–61.
CAS
PubMed
PubMed Central
Google Scholar
Kitamura T, Qian B-Z, Soong D, Cassetta L, Noy R, Sugano G, et al. CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages. J Exp Med. 2015;212:1043–59.
CAS
PubMed
PubMed Central
Google Scholar
Liao Z, Chua D, Tan NS. Reactive oxygen species: a volatile driver of field cancerization and metastasis. Mol Cancer. 2019;18:65.
PubMed
PubMed Central
Google Scholar
Ma J-Y, Hu G, Liu Q. Prognostic Significance of the Lymphocyte-to-Monocyte Ratio in Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis of 5638 Individuals. Dis Markers. 2019;2019:7593560.
PubMed
PubMed Central
Google Scholar
Yokota M, Katoh H, Nishimiya H, Kikuchi M, Kosaka Y, Sengoku N, et al. Lymphocyte-Monocyte Ratio Significantly Predicts Recurrence in Papillary Thyroid Cancer. J Surg Res. 2020;246:535–43.
CAS
PubMed
Google Scholar
Cananzi FCM, Minerva EM, Samà L, Ruspi L, Sicoli F, Conti L, et al. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors. J Surg Oncol. 2019;119:12–20.
PubMed
Google Scholar
Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer. 2005;113:752–60.
CAS
PubMed
Google Scholar
Palacios-Acedo AL, Mège D, Crescence L, Dignat-George F, Dubois C, Panicot-Dubois L. Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy. Front Immunol. 2019;10:1805.
CAS
PubMed
PubMed Central
Google Scholar
Abelardo E, Davies G, Kamhieh Y, Prabhu V. Are Inflammatory Markers Significant Prognostic Factors for Head and Neck Cancer Patients? ORL J Oto-Rhino-Laryngol Its Relat Spec. 2020;82:235–44.
Google Scholar
Rassouli A, Saliba J, Castano R, Hier M, Zeitouni AG. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. Head Neck. 2015;37:103–10.
PubMed
Google Scholar
Wang X, Cao K, Guo E, Mao X, An C, Guo L, et al. Assessment of immune status of laryngeal squamous cell carcinoma can predict prognosis and guide treatment. Cancer Immunol Immunother. 2021. https://doi.org/10.1007/s00262-021-03071-7.
Article
PubMed
PubMed Central
Google Scholar
Acharya S, Rai P, Hallikeri K, Anehosur V, Kale J. Preoperative platelet lymphocyte ratio is superior to neutrophil lymphocyte ratio to be used as predictive marker for lymph node metastasis in oral squamous cell carcinoma. J Investig Clin Dent. 2017;8:e12219.
Google Scholar
Zhang X, Zhao W, Yu Y, Qi X, Song L, Zhang C, et al. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis. World J Surg Oncol. 2020;18:191.
PubMed
PubMed Central
Google Scholar
Kim J-Y, Jung EJ, Kim J-M, Lee HS, Kwag S-J, Park J-H, et al. Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis. BMC Cancer. 2020;20:1206.
CAS
PubMed
PubMed Central
Google Scholar
Karpathiou G, Giroult JB, Forest F, Fournel P, Monaya A, Froudarakis M, et al. Clinical and Histologic Predictive Factors of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma. Am J Clin Pathol. 2016;146:546–53.
CAS
PubMed
Google Scholar